Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gelderblom

Showing results (151-160 of 251) with videos related to

Pageof 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2009
Reversibility of capillary density after discontinuation of bevacizumab treatmentN Steeghs, T J Rabelink, J op 't Roodt, et al.
Familial Cancer|December 13, 2005
Survival of patients with ovarian cancer due to a mismatch repair defectTh E M Crijnen, M L G Janssen-Heijnen, H Gelderblom, et al.
British Journal of Cancer|September 18, 2008
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer GroupD M Kweekel, M Koopman, N F Antonini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2018
Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database studyA J Verschoor, S Litière, S Marréaud, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 17, 2018
Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survivalS H Bakker, W C H Jacobs, W Pondaag, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studiesH Gelderblom, W J Loos, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2013
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumoursP Schöffski, D Adkins, J-Y Blay, et al.
European Journal of Psychotraumatology|May 5, 2023
Efficacy of eye movement desensitization and reprocessing therapy for fear of cancer recurrence among cancer survivors: a randomized single-case experimental designJ Bruin, Y R van Rood, K C M J Peeters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinibP Reichardt, J-Y Blay, H Gelderblom, et al.
British Journal of Cancer|November 17, 2001
Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancerH Gelderblom, A Sparreboom, M J de Jonge, et al.
Pageof 26

Showing results (151-160 of 251) with videos related to

Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2009
Reversibility of capillary density after discontinuation of bevacizumab treatmentN Steeghs, T J Rabelink, J op 't Roodt, et al.
Familial Cancer|December 13, 2005
Survival of patients with ovarian cancer due to a mismatch repair defectTh E M Crijnen, M L G Janssen-Heijnen, H Gelderblom, et al.
British Journal of Cancer|September 18, 2008
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer GroupD M Kweekel, M Koopman, N F Antonini, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2018
Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database studyA J Verschoor, S Litière, S Marréaud, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|September 17, 2018
Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survivalS H Bakker, W C H Jacobs, W Pondaag, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studiesH Gelderblom, W J Loos, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2013
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumoursP Schöffski, D Adkins, J-Y Blay, et al.
European Journal of Psychotraumatology|May 5, 2023
Efficacy of eye movement desensitization and reprocessing therapy for fear of cancer recurrence among cancer survivors: a randomized single-case experimental designJ Bruin, Y R van Rood, K C M J Peeters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinibP Reichardt, J-Y Blay, H Gelderblom, et al.
British Journal of Cancer|November 17, 2001
Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancerH Gelderblom, A Sparreboom, M J de Jonge, et al.
Pageof 26